loadpatents
name:-0.032178163528442
name:-0.010666847229004
name:-0.008303165435791
Bursavich; Matthew Gregory Patent Filings

Bursavich; Matthew Gregory

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bursavich; Matthew Gregory.The latest application filed is for "aminobenzisoxazole compounds as agonists of alpha7-nicotinic acetylcholine receptors".

Company Profile
5.8.27
  • Bursavich; Matthew Gregory - Needham MA
  • Bursavich; Matthew Gregory - Needham Heights UT US
  • Bursavich; Matthew Gregory - Tuckahoe NY
  • Bursavich; Matthew Gregory - Salt Lake City UT
  • Bursavich; Matthew Gregory - Sandy UT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Geminal substituted aminobenzisoxazole compounds as agonists of .alpha.7-nicotinic acetylcholine receptors
Grant 10,428,062 - Acharya , et al. October 1, 2
2019-10-01
Aminobenzisoxazole compounds as agonists of .alpha.7-nicotinic acetylcholine receptors
Grant 10,370,370 - Acharya , et al.
2019-08-06
Geminal substituted quinuclidine amide compounds as agonists of .alpha.-7 nicotonic acetylcholine receptors
Grant 10,183,938 - Acharya , et al. Ja
2019-01-22
Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
App 20180134696 - Acharya; Raksha ;   et al.
2018-05-17
Imidazotriazinone compounds
Grant 9,969,742 - Bursavich , et al. May 15, 2
2018-05-15
Geminal Substituted Quinuclidine Amide Compounds As Agonists Of Alpha-7 Nicotonic Acetylcholine Receptors
App 20170369486 - ACHARYA; Raksha ;   et al.
2017-12-28
Imidazotriazinone Compounds
App 20170327502 - Bursavich; Matthew Gregory ;   et al.
2017-11-16
Oxadiazine compounds and methods of use thereof
Grant 9,802,927 - Acharya , et al. October 31, 2
2017-10-31
Fused morpholinopyrimidines and methods of use thereof
Grant 9,771,378 - Burnett , et al. September 26, 2
2017-09-26
Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
App 20170247393 - Acharya; Raksha ;   et al.
2017-08-31
Imidazotriazinone compounds
Grant 9,725,453 - Bursavich , et al. August 8, 2
2017-08-08
Oxadiazine Compounds And Methods Of Use Thereof
App 20170066753 - Acharya; Raksha ;   et al.
2017-03-09
Oxadiazine Compounds And Methods Of Use Thereof
App 20170050980 - Burnett; Duane A. ;   et al.
2017-02-23
Fused Morpholinopyrimidines And Methods Of Use Thereof
App 20170044182 - Burnett; Duane A. ;   et al.
2017-02-16
Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors
App 20170044155 - Acharya; Raksha ;   et al.
2017-02-16
Compounds And Therapeutic Uses Thereof
App 20150353538 - Willardsen; J. Adam ;   et al.
2015-12-10
Amino-pyrimidine Compounds As Inhibitors Of Tbk1 And/or Ikk Epsilon
App 20150352108 - Holcomb; Ryan C. ;   et al.
2015-12-10
Imidazotriazinone Compounds
App 20150191476 - BURSAVICH; Matthew Gregory ;   et al.
2015-07-09
Compositions And Therapeutic Uses Of Ikk-related Kinase Epsilon And Tankbinding Kinase 1 Inhibitors
App 20140288044 - Holcomb; Ryan ;   et al.
2014-09-25
Compounds And Therapeutic Uses Thereof
App 20130317027 - Willardsen; J. Adam ;   et al.
2013-11-28
Compounds And Therapeutic Uses Thereof
App 20120329786 - Willardsen; J. Adam ;   et al.
2012-12-27
Amino-pyrimidine Compounds As Inhibitors Of Ikk Epsilon And/or Tbk1
App 20120238540 - HOLCOMB; Ryan C. ;   et al.
2012-09-20
Compounds And Therapeutic Uses Thereof
App 20120122840 - Kumar; Dange Vijay ;   et al.
2012-05-17
Anilino-pyrimidine analogs
Grant 7,799,915 - Sum , et al. September 21, 2
2010-09-21
4-phenoxy-6-aryl-1h-pyrazolo[3,4-d]pyrimidine And N-aryl-6-aryl-1h-pyrazolo[3,4-d]pyrimidin-4-amine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses
App 20100015141 - Bursavich; Matthew Gregory ;   et al.
2010-01-21
Piperazine Metabotropic Glutamate Receptor 5 (MGLUR5) Negative Allosteric Modulators For Anxiety/Depression
App 20090325964 - Bursavich; Matthew Gregory ;   et al.
2009-12-31
3-substituted-1h-indole Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses
App 20090311217 - Bursavich; Matthew Gregory ;   et al.
2009-12-17
3-substituted-1h-pyrrolo[2,3-b]pyridine And 3-substituted-1h-pyrrolo[3,2-b]pyridine Compounds, Their Use As Mtor Kinase And Pi3 Kinase Inhibitors, And Their Syntheses
App 20090298820 - Tsou; Hwei-Ru ;   et al.
2009-12-03
Pyrimidine Sulfonamide Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System
App 20090048282 - Hauze; Diane Barbara ;   et al.
2009-02-19
Heteroaryl/aryl Pyrimidine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System
App 20080287452 - BURSAVICH; Matthew Gregory ;   et al.
2008-11-20
Imidazolopyrimidine Analogs And Their Use As Pi3 Kinase And Mtor Inhibitors
App 20080233127 - Bursavich; Matthew Gregory ;   et al.
2008-09-25
Pyrazolopyrimidine Analogs And Their Use As Mtor Kinase And Pi3 Kinase Inhibitors
App 20080234262 - Zask; Arie ;   et al.
2008-09-25
Anilino-pyrimidine analogs
App 20060079543 - Sum; Fuk-Wah ;   et al.
2006-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed